GlassScriptPhysician profile
Leela Kumar Lella
NPI 1306162557
$46,270.94
in general payments reported to CMS, 2019-2025
40 companies · $5,449 in 2025
The $5,449 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,333 · 2020: $2,514 · 2021: $2,094 · 2022: $8,102 · 2023: $16K · 2024: $4,850 · 2025: $5,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Travel and Lodging: $7,150 · Education: $99.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,978.42 |
| Travel and Lodging | $7,150.27 |
| Education | $99.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,791.85 | 2021-2025 | Micra, Abre, Crome Dr Mri Surescan |
| Edwards Lifesciences Corporation | $5,767.06 | 2019-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $4,826.68 | 2019-2025 | Perclose Prostyle, Aveir, Cardiomems |
| Abiomed | $3,554.80 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $3,106.59 | 2019-2020 | |
| Penumbra, INC. | $2,906.96 | 2023 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $2,375.09 | 2020-2025 | Avvigo Guidance System, General - Balloon Catheters, Rotapro |
| Novartis Pharmaceuticals Corporation | $1,820.98 | 2019-2024 | |
| Amgen INC. | $1,251.91 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $1,186.43 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,028.29 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Amarin Pharma, INC. | $751.57 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $706.66 | 2019-2025 | Jardiance, Synjardy |
| Biotronik INC. | $552.41 | 2023 | Orsiro Mission, Trapit, Nhancer Rx |
| Actelion Pharmaceuticals US, INC. | $515.80 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $499.38 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $479.29 | 2020-2023 | Lifevest |
| Shockwave Medical, INC | $465.04 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $402.17 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Janssen Pharmaceuticals, INC | $344.99 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $326.62 | 2021-2025 | Verquvo, Winrevair |
| Cvrx, INC. | $215.69 | 2023-2025 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $177.85 | 2023-2025 | Amvuttra, Onpattro |
| Sanofi-Aventis U.S. LLC | $149.88 | 2019-2020 | |
| Philips North America LLC | $135.93 | 2020-2023 | |
| Novo Nordisk INC | $132.15 | 2024-2025 | Wegovy |
| Teleflex LLC | $129.85 | 2022-2025 | Turnpike, Guideliner |
| Ge Healthcare | $85.79 | 2025 | |
| Lilly USA, LLC | $85.38 | 2019-2020 | |
| Tactile Systems Technology INC | $84.98 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Idorsia Pharmaceuticals US INC | $67.57 | 2022-2023 | Quviviq |
| Baxter Healthcare | $66.90 | 2022 | |
| Lundbeck LLC | $48.99 | 2019-2020 | |
| Scpharmaceuticals INC. | $46.92 | 2025 | |
| Esperion Therapeutics, INC. | $44.81 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $42.37 | 2019 | |
| Inari Medical, INC. | $34.46 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biosense Webster, INC. | $25.12 | 2023 | Carto 3 |
| Cordis US Corp. | $24.30 | 2023 | Zephyr |
| Kowa Pharmaceuticals America, INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leela Lella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.